Surgical Artificial Intelligence Innovation Trends and Regulatory Insights: A Systematic Analysis of Food and Drug Administration-Approved Devices.
PMID: 42849513 ·
R, i, s, h, i, k, e, s, h, , G, a, n, d, h, e, w, a, r, ;, , A, h, m, a, d, , G, u, n, i, ;, , D, e, v, a, n, s, h, , T, a, n, d, o, n, ;, , S, o, n, a, m, , P, a, t, e, l, ;, , W, i, l, l, i, a, m, , W, a, l, d, o, c, k, ;, , N, a, f, i, , D, i, l, a, v, e, r, ;, , H, a, o, y, u, , Z, h, a, n, g, ;, , K, r, s, t, o, , P, a, n, d, z, a, ;, , A, r, a, , D, a, r, z, i, ;, , H, u, t, a, n, , A, s, h, r, a, f, i, a, n
Publicidade
Resumo
To characterise the landscape of surgical artificial intelligence (AI) devices approved by the US Food and Drug Administration (FDA). AI has the potential to improve surgical pathways, offering capability across screening, diagnosis, decision support, and intraoperative care. Despite this, real-world adoption remains limited. Regulatory approval serves as a key step in clinical translation but is influenced by challenges in evidence generation, safety, bias, transparency, and implementation. Con
Publicidade
Fonte oficial
Ver no PubMed →Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.